|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-7-2
|
|
pubmed:abstractText |
Semax had a pronounced neuroprotective and antiamnesic effect during focal photoinduced ischemia of the prefrontal cortex. Intranasal administration of Semax for 6 days decreased the volume of cortical infarction and improved retention and performance of conditioned passive avoidance response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0007-4888
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
663-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17603664-Administration, Intranasal,
pubmed-meshheading:17603664-Adrenocorticotropic Hormone,
pubmed-meshheading:17603664-Amnesia,
pubmed-meshheading:17603664-Animals,
pubmed-meshheading:17603664-Animals, Outbred Strains,
pubmed-meshheading:17603664-Brain Infarction,
pubmed-meshheading:17603664-Cerebral Cortex,
pubmed-meshheading:17603664-Ischemic Attack, Transient,
pubmed-meshheading:17603664-Male,
pubmed-meshheading:17603664-Neuroprotective Agents,
pubmed-meshheading:17603664-Peptide Fragments,
pubmed-meshheading:17603664-Rats,
pubmed-meshheading:17603664-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex.
|
|
pubmed:affiliation |
Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow, Russia. romanovaga@mail.ru
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
